Free Trial
NASDAQ:ATRC

AtriCure (ATRC) Stock Price, News & Analysis

AtriCure logo
$31.78 +0.39 (+1.24%)
As of 07/3/2025 01:04 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About AtriCure Stock (NASDAQ:ATRC)

Key Stats

Today's Range
$31.33
$32.03
50-Day Range
$29.07
$34.94
52-Week Range
$20.20
$43.11
Volume
166,072 shs
Average Volume
605,921 shs
Market Capitalization
$1.57 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$50.67
Consensus Rating
Buy

Company Overview

AtriCure Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
67th Percentile Overall Score

ATRC MarketRank™: 

AtriCure scored higher than 67% of companies evaluated by MarketBeat, and ranked 1015th out of 2,814 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    AtriCure has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 9 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    AtriCure has only been the subject of 3 research reports in the past 90 days.

  • Read more about AtriCure's stock forecast and price target.
  • Earnings Growth

    Earnings for AtriCure are expected to grow in the coming year, from ($0.60) to ($0.46) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of AtriCure is -39.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of AtriCure is -39.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    AtriCure has a P/B Ratio of 3.36. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about AtriCure's valuation and earnings.
  • Percentage of Shares Shorted

    3.27% of the float of AtriCure has been sold short.
  • Short Interest Ratio / Days to Cover

    AtriCure has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in AtriCure has recently decreased by 14.75%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    AtriCure does not currently pay a dividend.

  • Dividend Growth

    AtriCure does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.27% of the float of AtriCure has been sold short.
  • Short Interest Ratio / Days to Cover

    AtriCure has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in AtriCure has recently decreased by 14.75%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    AtriCure has a news sentiment score of 0.51. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for AtriCure this week, compared to 5 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, AtriCure insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $83,600.00 in company stock.

  • Percentage Held by Insiders

    Only 3.50% of the stock of AtriCure is held by insiders.

  • Percentage Held by Institutions

    99.11% of the stock of AtriCure is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about AtriCure's insider trading history.
Receive ATRC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AtriCure and its competitors with MarketBeat's FREE daily newsletter.

ATRC Stock News Headlines

AtriCure, Inc. (ATRC) - Yahoo Finance
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
ATRC Crosses Below Key Moving Average Level
See More Headlines

ATRC Stock Analysis - Frequently Asked Questions

AtriCure's stock was trading at $30.56 at the start of the year. Since then, ATRC shares have increased by 4.0% and is now trading at $31.78.

AtriCure, Inc. (NASDAQ:ATRC) posted its earnings results on Tuesday, April, 29th. The medical device company reported ($0.14) earnings per share for the quarter, topping the consensus estimate of ($0.25) by $0.11. The firm's revenue was up 13.5% compared to the same quarter last year.
Read the conference call transcript
.

The following companies are subsidiaries of AtriCure: SentreHEART.

Shares of ATRC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that AtriCure investors own include Meta Platforms (META), NVIDIA (NVDA), JPMorgan Chase & Co. (JPM), Tesla (TSLA), Advanced Micro Devices (AMD), Visa (V) and Home Depot (HD).

Company Calendar

Last Earnings
4/29/2025
Today
7/03/2025
Next Earnings (Estimated)
7/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:ATRC
Employees
1,300
Year Founded
2000

Price Target and Rating

Average Stock Price Target
$50.67
High Stock Price Target
$60.00
Low Stock Price Target
$44.00
Potential Upside/Downside
+59.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
9 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$44.70 million
Pretax Margin
-7.73%

Debt

Sales & Book Value

Annual Sales
$465.31 million
Price / Cash Flow
N/A
Book Value
$9.46 per share
Price / Book
3.36

Miscellaneous

Free Float
47,772,000
Market Cap
$1.57 billion
Optionable
Optionable
Beta
1.56

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:ATRC) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners